Description
Therapeutic action
– Uterine relaxant
– Antihypertensive drug (calcium channel blocker)
Indications
– Threatened premature labour
– Hypertension
Presentation
– 20 mg prolonged-release tablet
Dosage
– Threatened premature labour(short-acting capsule) 10 mg by oral route, to be repeated every 15 minutes if uterine contractions persist (maximum 4 doses or 40 mg), then 20 mg by oral route every 6 hours
–Hypertension (prolonged-release tablets)
20 to 100 mg/day in 2 divided doses or 20 to 90 mg once daily depending on the preparation used
Duration
–Threatened premature labour: 48 hours
–Hypertension: lifetime treatment
Contra-indications, adverse effects, precautions
– Do not administer to patients with severe cardiac disease (recent myocardial infarction, unstable angina).
– Do not administer if systolic blood pressure is below 90 mmHg.
– May cause:
- headache, flushing, peripheral oedema (common adverse effects at the start of treatment);
- dizziness, hypotension, tachycardia, nausea, gingival hyperplasia, rash.
– Stop nifedipine if ischaemic chest pain occurs or existing pain increases shortly after starting treatment.
– Do not combine with magnesium sulphate, salbutamol IV, and calcium channel blockers.
– Monitor combination with cimetidine (additive hypotension), phenytoin (risk of phenytoin toxicity), rifampicin (efficacy of nifedipine diminished), itraconazole (increased risk of oedema), be







Reviews
There are no reviews yet.